Head & Neck Cancer | Topics

Receipt of IMRT Is a Predictive Factors for Survival in Oropharyngeal Cancer, Study Shows
January 13, 2021

A study found that patients without recurrence of their oropharyngeal cancer at 5 years who were treated with intensity-modulated radiation therapy and had less tobacco exposure experienced optimal survival, but still had poorer outcomes when compared with the general population.

COVIDSurg Collaborative Finds Surgery for Head and Neck Cancer Is Safe During COVID-19 Pandemic
January 10, 2021

A group launched by the Global Health Research Unit of the National Institute for Health Research, which is currently seeking to determine the best surgical practices for cancer treatments, found that there is no additional risk of contracting COVID-19 for patients with cancer of the head and neck.

Biomarker Blood Test Offers Diagnostic Potential for HPV-Related Cancers
November 25, 2020

“This might raise the potential of being able to detect disease recurrence much earlier than current clinical practice,” said Thomas Weiland, MD.